Warburg effect

The Warburg effect refers to the specific metabolism of tumor cells, which have less functional mitochondria and significantly reduced oxidative phosphorylation compared to healthy cells. Here, ATP synthesis is compensated glycolytically with the simultaneous formation of lactate. The synonymous term aerobic glycolysis aerobní glykolýza. [[Soubor:Warburgův efekt2.jpg|náhled|Upraveno dle Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation . V obrázku byly použity šablony Servier Medical Art.]]

First half of the 20th century
In 1924, the German scientist Otto H. Warburg described this tumor phenotype in a somewhat simplified concept. Something similar was observed by Herbert G. Crabtree in yeast. He even confirmed that in case of an excess of glucose or fructose, there will be a temporary inhibition of respiration. Later, he decided to verify Warburg's claim not only on tumor cells, but also on various tissues. Crabtree concluded the work by stating that aerobic glycolysis is not the domain of malignant cells only, but is inherent to any increased pathological proliferation. Further experiments then led Crabtree to hypothesize that oxidative phosphorylation is key to the progression of specific tumors and that it is not possible to simply describe the metabolism of tumor tissue as predominantly glycolytic.

Warburg's uniqueness lies in the fact that he was the first to understand the importance of oxidation and reduction metabolic pathways in living organisms and was able to place them in the right context. He recieved the Nobel Prize for his work in 1931.

The hypothesis of non-functional or less functional mitochondria was only confirmed in 1951 by Feodor Lynen. In the 1950s, it was already possible to quantify the extent of oxidative phosphorylation and glycolysis, which prompted Otto Warburg, then director of the Max Planck Institute, to write a new summary paper. In it, he publishes a timeless hypothesis: " Energy itself will be the center of our thinking." Warburg already saw the weakness of tumor cells in the fact that they will use everything (not only glycolysis, but also oxidative phosphorylation, for example) to cover the enormous need for ATP.

The end of the 20th and the beginning of the 21st century
In the second half of the 20th century, a number of scientific groups focused on the possibility of using the Warburg effect as a target for antitumor therapy. The task was to selectively inhibit glycolysis and thus induce cell death. It turned out that it is not that simple, although it was possible to identify a number of pathological changes in the mitochondria of tumor cells. contributed to the modern perception of tumor metabolism only in 2004, Rodrigue Rossignol, who showed that the availability of energy substrates can change not only the oxidative capacity of tumor cells, but also the morphology of their mitochondria. Further studies have shown that tumor cells work on the principle of so-called metabolic remodeling. A number of solid tumor cells proliferate very quickly. At the same time, however, the malignant tissue does not manage to vascularize quickly enough. In similar cases, there is a temporary lack of substrates of oxidative phosphorylation or glycolysis. Not infrequently, there is also a decrease in oxygen concentration, which complicates the whole matter even more (see Reduktivní karboxylace).